Figure 5. Construction and evaluation of the novel nomogram. (A) The nomogram for predicting the survival probability of LUAD patients. The calibration plots of the nomogram for predicting OS probability in TCGA cohort (B) and GSE68465 cohort (C). Univariate (D) and multivariate (E) Cox analyses for the signature-based risk score and other clinical features in TCGA cohort. Univariate (F) and multivariate (G) Cox analyses for the signature-based risk score and other clinical features in GSE68465 cohort.